These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 26310815)

  • 21. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
    Haas L; Obenauf AC
    Front Immunol; 2019; 10():2746. PubMed ID: 31849950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.
    Terry S; Faouzi Zaarour R; Hassan Venkatesh G; Francis A; El-Sayed W; Buart S; Bravo P; Thiery J; Chouaib S
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced autophagy: a new player in cancer immunotherapy?
    Noman MZ; Janji B; Berchem G; Mami-Chouaib F; Chouaib S
    Autophagy; 2012 Apr; 8(4):704-6. PubMed ID: 22441015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
    Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
    Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of regulatory T cells in cancer.
    Stockis J; Roychoudhuri R; Halim TYF
    Immunology; 2019 Jul; 157(3):219-231. PubMed ID: 31032905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia and acidosis: immune suppressors and therapeutic targets.
    Damgaci S; Ibrahim-Hashim A; Enriquez-Navas PM; Pilon-Thomas S; Guvenis A; Gillies RJ
    Immunology; 2018 Jul; 154(3):354-362. PubMed ID: 29485185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer.
    Toor SM; Elkord E
    Immunol Cell Biol; 2018 Oct; 96(9):888-897. PubMed ID: 29635843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Microenvironment, Tumor Immunity and Immunotherapy.
    Lamplugh Z; Fan Y
    Front Immunol; 2021; 12():811485. PubMed ID: 34987525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Hypoxia-ALCAM
    Xun Z; Zhou H; Shen M; Liu Y; Sun C; Du Y; Jiang Z; Yang L; Zhang Q; Lin C; Hu Q; Ye Y; Han L
    Adv Sci (Weinh); 2024 Sep; 11(33):e2309885. PubMed ID: 38956900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia Compromises Anti-Cancer Immune Responses.
    Multhoff G; Vaupel P
    Adv Exp Med Biol; 2020; 1232():131-143. PubMed ID: 31893404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches.
    Klein K; He K; Younes AI; Barsoumian HB; Chen D; Ozgen T; Mosaffa S; Patel RR; Gu M; Novaes J; Narayanan A; Cortez MA; Welsh JW
    Front Immunol; 2020; 11():573326. PubMed ID: 33178201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy.
    Meybodi SM; Ejlalidiz M; Manshadi MR; Raeisi M; Zarin M; Kalhor Z; Saberiyan M; Hamblin MR
    Crit Rev Oncol Hematol; 2024 May; 197():104340. PubMed ID: 38570176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors.
    Schurich A; Magalhaes I; Mattsson J
    Immunotherapy; 2019 Mar; 11(4):335-345. PubMed ID: 30678555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment.
    Ou X; Lv W
    Future Oncol; 2020 Mar; 16(8):383-393. PubMed ID: 32067476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.